StockDriftsStockDriftsTop 4 Mpm Asset Management Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | 57.09% | 4.38M | $25.4M | +0.00%(+0) | $23.45(-52.63%) | 2025-09-30 | |
| DYN | Dyne Therapeutics, Inc. | 19.4% | 682.4K | $8.6M | +0.00%(+0) | $23.36(-20.60%) | 2025-09-30 | |
| HOWL | Werewolf Therapeutics, Inc. | 19.08% | 4.31M | $8.5M | +0.00%(+0) | $15.40(-95.62%) | 2025-09-30 | |
| RPTX | Repare Therapeutics, Inc. | 4.43% | 1.12M | $2.0M | +0.00%(+0) | $31.79(-93.24%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (12 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | -5.22% | -14.86% | — | — | -14.86% |
| Top 20 Holdings Unweighted | -3.16% | -9.17% | — | — | -9.17% |
Mpm Asset Management Llc reports $44.51M in US-listed equity holdings across 4 positions in its most recent 13F filing. Its largest disclosed positions are TRDA (57.1%), DYN (19.4%) and HOWL (19.1%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -14.86% on a three-year cumulative basis. Figures reflect the Q3 2025 filing.
Sign up free to track Mpm Asset Management Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Mpm Asset Management Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1263048). View Mpm Asset Management Llc’s 13F filings on SEC